BPH GlobalASX:BP8 +100.00% OCF Margin % is -80.52% as of Dec. 2025. The stock has 6 warning signs investors should review. Among 959 Drug Manufacturers companies, BPH Global ranks worse than 92.91% on this metric.
The historical rank and industry rank for BPH Global's OCF Margin % or its related term are showing as below:
ASX:BP8'
s OCF Margin % Range Over the Past 10 Years
Min: -1286.67 Med: -264.2 Max: -15.83
Current: -102.09
During the past 13 years, the highest OCF Margin % of BPH Global was -15.83%. The lowest was -1286.67%. And the median was -264.20%.
ASX:BP8's OCF Margin % is ranked worse than 92.91% of 959
companies
in the Drug Manufacturers industry
Industry Median: 9.95
vs ASX:BP8: -102.09
BPH Global OCF Margin % Related Terms
BPH Global OCF Margin % Historical Data
* Premium members only.
The historical data trend for BPH Global's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, BPH Global's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BPH Global OCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, BPH Global's OCF Margin % distribution charts can be found below:
* The bar in red indicates where BPH Global's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BPH Global (ASX:BP8) has a OCF Margin % of -80.52% as of Dec. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on BPH Global and its competitors. According to the industry distribution chart, BPH Global ranks #891 out of 959 companies in the Drug Manufacturers industry, placing it in the top 92.9%.
Is BPH Global's OCF Margin % too high?
BPH Global's current OCF Margin % is -80.52%. Based on the distribution chart, BPH Global ranks #891 out of 959 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers.
How does BPH Global's OCF Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, BPH Global ranks #891 out of 959 companies for OCF Margin %. This places BPH Global in the lower half of its industry. The industry median OCF Margin % is 9.95. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Drug Manufacturers company?
The median OCF Margin % among Drug Manufacturers companies is 9.95, based on 959 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on BPH Global and its competitors. For the Drug Manufacturers industry, the median OCF Margin % is 9.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. BPH Global's current OCF Margin % is -80.52%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BPH Global stock overvalued right now?
BPH Global (ASX:BP8) has a current OCF Margin % of -80.52%. The current OCF Margin % is -80.52%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For BPH Global (ASX:BP8), the current OCF Margin % is -80.52% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
BPH Global Ltd is a plant-focused biotechnology company with a focus on producing foods, health, and cosmetic products that deliver Traditional Chinese Medicine (TCM)-based health outcomes. It focuses on the research, development, production, and commercialization of TCM products, including bird's nest, seaweeds, and sea plants, which serve as sustainable plant-based protein sources and ingredients for food, nutrition, healthcare, cosmetics, and personal care industries. The company's geographical segment includes Australia, Indonesia, and China. The company's products comprise raw and processed bird's nest, sea grapes (Caulerpa lentillifera), and other seaweeds and sea plants.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:BP8 has been successfully added to your 